Vaxart Investors Seek Initial OK Of $12M Deal In Fraud Suit

By Sarah Jarvis · August 22, 2022, 9:48 PM EDT

A proposed class of investors in Vaxart has urged a California federal court to give its initial OK to a $12 million settlement with the biotechnology company over allegations it pumped...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Motion

Case Information

Case Title

In re Vaxart, Inc. Securities Litigation

Case Number

Court

California Northern

Nature of Suit

Securities/Commodities

Date Filed

August 24, 2020

Recent Articles By Sarah

July 19, 2024
DaVita To Pay $34M In Medicare Kickback Whistleblower Suit
June 28, 2024
Ontrak Exec Conviction Shows Trading Plans Aren't Shields
April 15, 2024
Mental Health Co. Cerebral To Pay $7M Over Data Failures
March 12, 2024
2nd Circ. Revives Parts Of McKesson Whistleblower Suit
March 11, 2024
Pfizer Slams Ex-Compliance Officer's Whistleblower Claims
October 10, 2023
Justices Hint At Siding With Whistleblower Against UBS
October 06, 2023
5 Things To Know About High Court Whistleblower Case
September 13, 2023
Biz Groups Urge CFPB To Not Go After Medical Credit Cards
July 28, 2023
The Compliance Chiefs Who've Faced Legal Hot Water In '23
June 29, 2023
Pharma CEO, Others Get Prison Time In $80M Medicare Fraud